Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 7 ( July, 2022 ) > List of Articles

Original Article

Noninvasive Respiratory Assist Devices in the Management of COVID-19-related Hypoxic Respiratory Failure: Pune ISCCM COVID-19 ARDS Study Consortium (PICASo)

Sameer Jog, Kapil Zirpe, Manasi Shahane, Kayanoosh Kadapatti, Kapil Borawake, Zafer Khan, Urvi Shukla, Ashwini Jahagirdar, Venkatesh Dhat, Pradeep D'costa, Jayant Shelgaonkar, Abhijit Deshmukh, Khalid Khatib

Keywords : High-flow nasal oxygen, Mechanical ventilation, Moderate-to-severe acute respiratory distress syndrome, Noninvasive ventilation

Citation Information : Jog S, Zirpe K, Shahane M, Kadapatti K, Borawake K, Khan Z, Shukla U, Jahagirdar A, Dhat V, D'costa P, Shelgaonkar J, Deshmukh A, Khatib K. Noninvasive Respiratory Assist Devices in the Management of COVID-19-related Hypoxic Respiratory Failure: Pune ISCCM COVID-19 ARDS Study Consortium (PICASo). Indian J Crit Care Med 2022; 26 (7):791-797.

DOI: 10.5005/jp-journals-10071-24241

License: CC BY-NC 4.0

Published Online: 15-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Objective: To determine whether high-flow nasal oxygen (HFNO) or noninvasive ventilator (NIV) can avoid invasive mechanical ventilation (IMV) in COVID-19-related acute respiratory distress syndrome (ADRS), and the outcome predictors of these modalities. Design: Multicenter retrospective study conducted in 12 ICUs in Pune, India. Patients: Patients with COVID-19 pneumonia who had PaO2/FiO2 ratio <150 and were treated with HFNO and/or NIV. Intervention: HFNO and/or NIV. Measurements: The primary outcome was to assess the need of IMV. Secondary outcomes were death at Day 28 and mortality rates in different treatment groups. Main results: Among 1,201 patients who met the inclusion criteria, 35.9% (431/1,201) were treated successfully with HFNO and/or NIV and did not require IMV. About 59.5% (714/1,201) patients needed IMV for the failure of HFNO and/or NIV. About 48.3, 61.6, and 63.6% of patients who were treated with HFNO, NIV, or both, respectively, needed IMV. The need of IMV was significantly lower in the HFNO group (p <0.001). The 28-day mortality was 44.9, 59.9, and 59.6% in the patients treated with HFNO, NIV, or both, respectively (p <0.001). On multivariate regression analysis, presence of any comorbidity, SpO2 <90%, and presence of nonrespiratory organ dysfunction were independent and significant determinants of mortality (p <0.05). Conclusions: During COVID-19 pandemic surge, HFNO and/or NIV could successfully avoid IMV in 35.5% individuals with PO2/FiO2 ratio <150. Those who needed IMV due to failure of HFNO or NIV had high (87.5%) mortality.

  1. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574–1581. DOI: 10.1001/jama.2020.5394.
  2. Ranieri VM, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526–2533. DOI: 10.1001/jama.2012.5669.
  3. Brochard L, Lefebvre J-C, Cordioli RL, Akoumianaki E, Richard J-CM. Noninvasive ventilation for patients with hypoxemic acute respiratory failure. In: Seminars in respiratory and critical care medicine. Thieme Medical Publishers; 2014. p. 492–500.
  4. Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426. DOI: 10.1183/13993003.02426-2016.
  5. Chawla R, Khilnani GC, Suri JC, Ramakrishnan N, Mani RK, Prayag S, et al. Guidelines for noninvasive ventilation in acute respiratory failure. Indian J Crit Care Med 2006;10(2):117–147. DOI: 10.4103/0972-5229.25926.
  6. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196. DOI: 10.1056/NEJMoa1503326.
  7. Demoule A, Hill N, Navalesi P. Can we prevent intubation in patients with ARDS? Intensive Care Med 2016;42(5):768–771. DOI: 10.1007/s00134-016-4323-6.
  8. Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, et al. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care 2015;60(2):170–178. DOI: 10.4187/respcare.03075.
  9. Bellani G, Laffey JG, Pham T, Madotto F, Fan E, Brochard L, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome. Insights from the LUNG SAFE study. Am J Respir Crit Care Med 2017;195(1):67–77. DOI: 10.1164/rccm.201606-1306OC.
  10. Rosner B. Fundamentals of biostatistics. Cengage Learning; 2015.
  11. Sundar PS, Richard RJ. An introduction to biostatistics, a manual for students in Health sciences, Eastern Economy edition. New Delhi: Prentice-hall of India Plc; 2004.
  12. Nava S, Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009;374(9685):250–259. DOI: 10.1016/S0140-6736(09)60496-7.
  13. Antonelly M, Conti G, Esquinas A. A multiple-centre survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 2007;35(1):18–25. DOI: 10.1097/01.CCM.0000251821.44259.F3.
  14. Wang JG, Liu B, Percha B, Pan S, Goel N, Mathews KS, et al. Cardiovascular disease and severe hypoxemia are associated with higher rates of noninvasive respiratory support failure in coronavirus disease 2019 pneumonia. Crit Care Explor 2021;3(3):e0355. DOI: 10.1097/CCE.0000000000000355.
  15. Kerai S, Singh R, Saxena KN, Desai SD, Bhalotra AR. A retrospective study on experience of high-flow nasal cannula oxygen in critically ill COVID-19 adult patients admitted to intensive care unit. Indian J Crit Care Med Peer-reviewed, Off Publ Indian Soc Crit Care Med 2022;26(1):62. DOI: 10.5005/jp-journals-10071-24097.
  16. Mellado-Artigas R, Ferreyro BL, Angriman F, Hernández-Sanz M, Arruti E, Torres A, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care 2021;25(1): 1–10. DOI: 10.1186/s13054-021-03469-w.
  17. Vega ML, Dongilli R, Olaizola G, Colaianni N, Sayat MC, Pisani L, et al. COVID-19 pneumonia and ROX index: time to set a new threshold for patients admitted outside the ICU. Authors’ reply. Pulmonology 2021;27(5):475–476. DOI: 10.1016/j.pulmoe.2021.07.001.
  18. Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, et al. High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study. Ann Intensive Care 2021;11(1):1–9. DOI: 10.1186/s13613-021-00825-5.
  19. Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMedicine 2020;28:100570. DOI: 10.1016/j.eclinm.2020.100570.
  20. Rorat M, Szymański W, Jurek T, Karczewski M, Zelig J, Simon K. When conventional oxygen therapy fails—the effectiveness of high-flow nasal oxygen therapy in patients with respiratory failure in the course of COVID-19. J Clin Med 2021;10(20):4751. DOI: 10.3390/jcm10204751.
  21. Bertaina M, Nuñez-Gil IJ, Franchin L, Rozas IF, Arroyo-Espliguero R, Viana-Llamas MC, et al. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry. Emerg Med J 2021;38(5):359–365. DOI: 10.1136/emermed-2020-210411.
  22. Bellani G, Grasselli G, Cecconi M, Antolini L, Borelli M, De Giacomi F, et al. Noninvasive ventilatory support of patients with COVID-19 outside the intensive care units (WARd-COVID). Ann Am Thorac Soc 2021;18(6):1020–1026. DOI: 10.1513/AnnalsATS.202008-1080OC.
  23. Coppadoro A, Benini A, Fruscio R, Verga L, Mazzola P, Bellelli G, et al. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care 2021;25(1):1–10. DOI: 10.1186/s13054-021-03502-y.
  24. Alviset S, Riller Q, Aboab J, Dilworth K, Billy P-A, Lombardi Y, et al. Continuous positive airway pressure (CPAP) face-mask ventilation is an easy and cheap option to manage a massive influx of patients presenting acute respiratory failure during the SARS-CoV-2 outbreak: a retrospective cohort study. PLoS One 2020;15(10):e0240645. DOI: 10.1371/journal.pone.0240645.
  25. De Vita N, Scotti L, Cammarota G, Racca F, Pissaia C, Maestrone C, et al. Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure. Pulmonology 2021;S2531-0437(21)00002-7. DOI: 10.1016/j.pulmoe.2020.12.010.
  26. Vaschetto R, Barone-Adesi F, Racca F, Pissaia C, Maestrone C, Colombo D, et al. Outcomes of COVID-19 patients treated with continuous positive airway pressure outside the intensive care unit. ERJ Open Res 2021;7(1):00541-2020. DOI: 10.1183/23120541.00541-2020.
  27. Mukhtar A, Lotfy A, Hasanin A, El-Hefnawy I, El Adawy A. Outcome of non-invasive ventilation in COVID-19 critically ill patients: a retrospective observational study. Anaesthesia, Crit Care Pain Med 2020;39(5):579. DOI: 10.1016/j.accpm.2020.07.012.
  28. Daniel P, Mecklenburg M, Massiah C, Joseph MA, Wilson C, Parmar P, et al. Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support. Am J Emerg Med 2021;43:103–108. DOI: 10.1016/j.ajem.2021.01.068.
  29. Duan J, Chen B, Liu X, Shu W, Zhao W, Li J, et al. Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: a multicenter observational study. Am J Emerg Med 2021;46:276–281. DOI: 10.1016/j.ajem.2020.07.071.
  30. Jha OK, Kumar S, Mehra S, Sircar M, Gupta R. Helmet NIV in acute hypoxemic respiratory failure due to COVID-19: change in PaO2/FiO2 ratio a predictor of success. Indian J Crit Care Med Peer-reviewed, Off Publ Indian Soc Crit Care Med 2021;25(10):1137. DOI: 10.5005/jp-journals-10071-23992.
  31. McDonough G, Khaing P, Treacy T, McGrath C, Yoo EJ. The use of high-flow nasal oxygen in the ICU as a first-line therapy for acute hypoxemic respiratory failure secondary to coronavirus disease 2019. Crit care Explor 2020;2(10):e0257. DOI: 10.1097/CCE.0000000000000257.
  32. Liu L, Xie J, Wu W, Chen H, Li S, He H, et al. A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study. Lancet Digit Heal 2021;3(3):e166–e174. DOI: 10.1016/S2589-7500(20)30316-2.
  33. Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019;199(11):1368–1376. DOI: 10.1164/rccm.201803-0589OC.
  34. Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med 2017;43(2):192–199. DOI: 10.1007/s00134-016-4601-3.
  35. Carrillo A, Lopez A, Carrillo L, Caldeira V, Guia M, Alonso N, et al. Validity of a clinical scale in predicting the failure of non-invasive ventilation in hypoxemic patients. J Crit Care 2020;60:152–158. DOI: 10.1016/j.jcrc.2020.08.008.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.